Cite
HARVARD Citation
Lebbé, C. et al. (n.d.). LBA47Initial results from a phase IIIb/IV study evaluating two dosing regimens of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 511). Annals of oncology. p. . [Online].